Indication
Treatment of severe alopecia areata in adults and adolescents aged 12 years and over.
Medicine details
- Medicine name:
- ritlecitinib (Litfulo)
- SMC ID:
- SMC2610
- Pharmaceutical company
- Pfizer Ltd
- BNF chapter
- Skin
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- TBC